Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L. Diodati is active.

Publication


Featured researches published by L. Diodati.


Journal of Clinical Oncology | 2018

Correlation of expression of TK1 in plasma-derived exosomes with clinical response to CDK4/6 inhibitors in breast cancer.

Marzia Del Re; Andrea Fontana; Stefania Crucitta; Ilaria Bertolini; Eleonora Rofi; Claudia De Angelis; L. Diodati; Diletta Cavallero; Barbara Salvadori; Alfredo Falcone; Riccardo Morganti; Romano Danesi


Journal of Clinical Oncology | 2018

Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.

Marina Cazzaniga; Paolo Pronzato; Icro Meattini; Laura Biganzoli; Cristiana Taverniti; Sabino De Placido; Caterina Aversa; Elio Bordin; Monica Giordano; Alessandra Bologna; L. Diodati; Livio Blasi; Ornella Garrone; Emanuela Romagnoli; Carmela Mocerino; A. D'Alonzo; Michela Piezzo; Giorgio Mustacchi


Annals of Oncology | 2018

145PExpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer

Stefania Crucitta; M. Del Re; A Fontana; Ilaria Bertolini; Eleonora Rofi; C. De Angelis; L. Diodati; D Cavallero; B Salvadori; Alfredo Falcone; Riccardo Morganti; Romano Danesi


SciFed Oncology & Cancer Research Journal | 2017

Bilateral Anterior Uveitis Following Zoledronic Acid Therapy In BreastCancer: A Case Report

Barbara Salvadori; Ilaria Ferrarini; Ilaria Bertolini; Claudia De Angelis; L. Diodati; A Fontana; AndreaAntonuzzo; Alfredo Falcone


Annals of Oncology | 2017

C65Are anti-HER2 agents the best choice in metastatic breast cancer with an HER2 positive switch from primary tumour? A retrospective multi institution analysis of clinical-pathological characteristics and outcomes

Ilaria Bertolini; L. Diodati; A. Fontana; C. De Angelis; L. Cantini; S Cecconi; I. Montagnani; Barbara Salvadori; I. Ferrarini; P. Ferrari; Andrea Michelotti; Elisabetta Landucci; G Fanelli; Cristian Scatena; A G Naccarato; Rossana Berardi; M Pistelli


Annals of Oncology | 2017

C62Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) in HER2 negative metastatic breast cancer (mBC) patients (PTS) as second-line (2L) and beyond: a restrospective single institution analysis

C. De Angelis; L. Diodati; Ilaria Bertolini; I. Montagnani; A. Fontana; I. Ferrarini; Barbara Salvadori; P. Ferrari; Andrea Michelotti; Elisabetta Landucci


Annals of Oncology | 2017

C46Prognostic value of lymph node ratio in early breast cancer: a restrospective single institution analysis of clinical-pathological characteristics and outcomes

L. Diodati; C. De Angelis; Ilaria Bertolini; I. Montagnani; Barbara Salvadori; P. Ferrari; A. Fontana


Annals of Oncology | 2016

F34Retrospective observational analysis of bevacizumab (BV) plus paclitaxel (TXL) as first line treatment in metastatic HER2 negative breast cancer (BC): are BV long responders a different subgroup?

Ilaria Bertolini; C. De Angelis; L. Diodati; F. Ilaria; M.G. Bianco; A. Fontana; Andrea Michelotti; Barbara Salvadori; Elisabetta Landucci; E. Pfanner; P. Ferrari; C. Orlandini


Annals of Oncology | 2016

F35Young women with metastatic breast cancer (mbc): a restrospective single institution analysis of clinical-pathological characteristics and outcomes

A. Fontana; L. Diodati; Ilaria Bertolini; C. De Angelis; I. Ferrarini; Barbara Salvadori; Andrea Michelotti; Elisabetta Landucci; E. Pfanner; P. Ferrari; M. Lo Russo; L. Fustagno; E. Rossetti; M. Ghilli; M. Roncella


Annals of Oncology | 2016

F43Neoadjuvant Chemotherapy among Breast Cancer subtypes: a single-institution retrospective study

I. Ferrarini; A. Fontana; Ilaria Bertolini; L. Diodati; C. De Angelis; I. Montagnani; Barbara Salvadori; M. Ghilli; Elisabetta Landucci; M. Lo Russo; E. Pfanner; E. Rossetti; P. Ferrari; L. Fustaino; Andrea Michelotti; M. Roncella

Collaboration


Dive into the L. Diodati's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. De Angelis

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Fontana

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge